Introduction:

Shanghai Pharmaceuticals Holding Co. Ltd. (“SPH”) is a vertically-integrated and diversified pharmaceutical group. The company has dual listings on the stock exchanges in Shanghai (601607) and Hong Kong (02067) respectively. The company provides leading healthcare services in: Research & Development, Manufacturing, Distribution and Retail.

In 2019, SPH reported revenues of US$26.5bn, making the company one of the country’s major forces in the industry. SPH is one of the few listed pharmaceutical companies with a leading position in both manufacturing and distribution in China. It is included in the constituent stocks of both the SSE 180 and CSI 300 indices, and also selected into the Hang Seng Composite Index and MSCI.

Keyword:

pharmaceutical

Product Picture: